NRIX

NRIX

USD

Nurix Therapeutics Inc. Common stock

$12.260-0.040 (-0.325%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$12.300

Máximo

$12.530

Mínimo

$12.160

Volumen

1.16M

Fundamentos de la Empresa

Capitalización de Mercado

1.2B

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

1.24M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $8.18Actual $12.260Máximo $29.56

Noticias Relacionadas

Analyst Upgrades

Needham Reiterates Buy on Nurix Therapeutics, Maintains $26 Price Target

Needham analyst Gil Blum reiterates Nurix Therapeutics with a Buy and maintains $26 price target.

Ver más
Needham Reiterates Buy on Nurix Therapeutics, Maintains $26 Price Target
Analyst Upgrades

BTIG Reiterates Buy on Nurix Therapeutics, Maintains $27 Price Target

BTIG analyst Jeet Mukherjee reiterates Nurix Therapeutics with a Buy and maintains $27 price target.

Ver más
BTIG Reiterates Buy on Nurix Therapeutics, Maintains $27 Price Target
GlobeNewswire

Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein

Ver más
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
GlobeNewswire

Nurix Therapeutics to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein

Ver más
Nurix Therapeutics to Participate in Upcoming Investor Conferences

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.